ReP USP - Resultado da busca

Artigo de periodico
Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19 (2021)
Restrepo, Jeffersson Leandro Jimenez ; Codo, Ana Campos ; Sampaio, Vanderson de Souza; Oliveira, Antonio Edson Rocha; Ferreira, Lucas Kaoru Kobo; Davanzo, Gustavo Gastão ; Monteiro, Lauar de Brito ; Silva, João Victor Virgilio da ; Borba, Mayla Gabriela Silva; Souza, Gabriela Fabiano de ; Zini, Nathalia ; Gandolfi, Flora de Andrade; Muraro, Stéfanie Primon ; Módena, José Luiz Proença ; Val, Fernando Almeida; Melo, Gisely Cardoso; Monteiro, Wuelton Marcelo; Nogueira, Mauricio Lacerda ; Lacerda, Marcus Vinicius Guimarães ; Vieira, Pedro M. Moraes; Nakaya, Helder Takashi Imoto
Source: Frontiers in Medicine. Unidades: FCF, FFLCH
Assunto: COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RESTREPO, Jeffersson Leandro Jimenez et al. Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19. Frontiers in Medicine, v. 8, p. 1-8 art. 637885, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmed.2021.637885. Acesso em: 07 nov. 2024.
APA
Restrepo, J. L. J., Codo, A. C., Sampaio, V. de S., Oliveira, A. E. R., Ferreira, L. K. K., Davanzo, G. G., et al. (2021). Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19. Frontiers in Medicine, 8, 1-8 art. 637885. doi:10.3389/fmed.2021.637885
NLM
Restrepo JLJ, Codo AC, Sampaio V de S, Oliveira AER, Ferreira LKK, Davanzo GG, Monteiro L de B, Silva JVV da, Borba MGS, Souza GF de, Zini N, Gandolfi F de A, Muraro SP, Módena JLP, Val FA, Melo GC, Monteiro WM, Nogueira ML, Lacerda MVG, Vieira PMM, Nakaya HTI. Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19 [Internet]. Frontiers in Medicine. 2021 ; 8 1-8 art. 637885.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fmed.2021.637885
Vancouver
Restrepo JLJ, Codo AC, Sampaio V de S, Oliveira AER, Ferreira LKK, Davanzo GG, Monteiro L de B, Silva JVV da, Borba MGS, Souza GF de, Zini N, Gandolfi F de A, Muraro SP, Módena JLP, Val FA, Melo GC, Monteiro WM, Nogueira ML, Lacerda MVG, Vieira PMM, Nakaya HTI. Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19 [Internet]. Frontiers in Medicine. 2021 ; 8 1-8 art. 637885.[citado 2024 nov. 07 ] Available from: https://doi.org/10.3389/fmed.2021.637885
Artigo de periodico
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial (2021)
Jeronimo, Christiane Maria Prado; Farias, Maria Eduarda Leao; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Alexandre, Marcia Almeida Araujo; Melo, Gisely Cardoso; Safe, Izabella Picinin; Borba, Mayla Gabriela Silva; Abreu Netto, Rebeca Linhares; Maciel, Alex Bezerra Silva; Hajjar, Ludhmila Abrahão
Source: Clinical infectious diseases. Unidade: FM
Subjects: PACIENTES INTERNADOS, COVID-19, HORMÔNIOS DO CÓRTEX ADRENAL, ANTI-INFLAMATÓRIOS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JERONIMO, Christiane Maria Prado et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clinical infectious diseases, v. 72, n. 9, p. E373-E381, 2021Tradução . . Disponível em: https://doi.org/10.1093/cid/ciaa1177. Acesso em: 07 nov. 2024.
APA
Jeronimo, C. M. P., Farias, M. E. L., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., et al. (2021). Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clinical infectious diseases, 72( 9), E373-E381. doi:10.1093/cid/ciaa1177
NLM
Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Abreu Netto RL, Maciel ABS, Hajjar LA. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial [Internet]. Clinical infectious diseases. 2021 ; 72( 9): E373-E381.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/cid/ciaa1177
Vancouver
Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Abreu Netto RL, Maciel ABS, Hajjar LA. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial [Internet]. Clinical infectious diseases. 2021 ; 72( 9): E373-E381.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/cid/ciaa1177
Artigo de periodico
Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial (2020)
Borba, Mayla Gabriela Silva; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Alexandre, Marcia Almeida Araujo; Melo, Gisely Cardoso; Brito, Marcelo; Mourao, Maria Paula Gomes; Brito-sousa, Jose Diego; Baia-da-Silva, Djane; Hajjar, Ludhmila Abrahão
Source: Jama network open. Unidade: FM
Subjects: COVID-19, ANTIVIRAIS, SURTOS DE DOENÇAS, MÉTODO DUPLO-CEGO, PNEUMONIA, ATENÇÃO TERCIÁRIA À SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORBA, Mayla Gabriela Silva et al. Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. Jama network open, v. 3, n. 4, 2020Tradução . . Disponível em: https://doi.org/10.1001/jamanetworkopen.2020.8857. Acesso em: 07 nov. 2024.
APA
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., et al. (2020). Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. Jama network open, 3( 4). doi:10.1001/jamanetworkopen.2020.8857
NLM
Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourao MPG, Brito-sousa JD, Baia-da-Silva D, Hajjar LA. Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial [Internet]. Jama network open. 2020 ; 3( 4):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1001/jamanetworkopen.2020.8857
Vancouver
Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourao MPG, Brito-sousa JD, Baia-da-Silva D, Hajjar LA. Effect of high vs low doses of Chloroquine Diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial [Internet]. Jama network open. 2020 ; 3( 4):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1001/jamanetworkopen.2020.8857

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies